23andMe Partners With Pfizer to Research Genetics of Inflammatory Bowel Disease
IBD News, News
California-based personal genetics company 23andMe recently partnered with Pfizer to enroll 10,000 patients with Inflammatory Bowel Disease in a research initiative that will explore how genetics and environment are associated with ... Read more